MedPath

Diagnostic accuracy of 68 Ga PSMA PET CT scan in adeno carcinoma prostate

Not Applicable
Conditions
Health Condition 1: null- Diagnosed with adeno carcinoma prostate
Registration Number
CTRI/2017/12/010968
Lead Sponsor
Kerala Institute of medical sciencesTrivandrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Biopsy proven adenocarcinoma prostate

2. Age < 75 years

Exclusion Criteria

1. Other histologies of Prostate carcinoma.

2. Claustrophobia or absolute contraindications for MRI.

3. Patients with impaired renal function / other absolute contraindications for i.v contrast

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
diagnostic accuracy of 68Ga-PSMA PET/CT scan in the initial staging work up of patients with prostate adenocarcinoma compared with a gold standard comprising MRI pelvis, 99mTc MDP bone scan and CECT abdomen.Timepoint: from july first 2016 to first july 2018
Secondary Outcome Measures
NameTimeMethod
1. To compare the sensitivity and specificity in diagnosing pelvic bone metastasis in patients with prostate adenocarcinoma using 68Ga-PSMA PET/CT scan against MRI pelvis against 99mTc MDP bone scan. <br/ ><br>2. To compare the sensitivity and specificity in diagnosing soft tissue, lymph nodal and bony metastasis in patients with prostate adenocarcinoma using 68Ga-PSMA PET/CT scan against 68Ga-PSMA PET/NCCT. <br/ ><br>3. Usefulness of delayed imaging in detection of pelvic lymph nodal metastasis. <br/ ><br>Timepoint: 2 years
© Copyright 2025. All Rights Reserved by MedPath